Cargando…
Statement for Appropriate Clinical Use of PCSK9 Inhibitors
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099074/ https://www.ncbi.nlm.nih.gov/pubmed/29899173 http://dx.doi.org/10.5551/jat.45229 |
_version_ | 1783348588283166720 |
---|---|
author | Nohara, Atsushi Ohmura, Hirotoshi Okazaki, Hiroaki Ogura, Masatsune Kitagawa, Kazuo Koseki, Masahiro Sato, Kayoko Tsukamoto, Kazuhisa Yamashita, Shizuya |
author_facet | Nohara, Atsushi Ohmura, Hirotoshi Okazaki, Hiroaki Ogura, Masatsune Kitagawa, Kazuo Koseki, Masahiro Sato, Kayoko Tsukamoto, Kazuhisa Yamashita, Shizuya |
author_sort | Nohara, Atsushi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6099074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Japan Atherosclerosis Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-60990742018-08-21 Statement for Appropriate Clinical Use of PCSK9 Inhibitors Nohara, Atsushi Ohmura, Hirotoshi Okazaki, Hiroaki Ogura, Masatsune Kitagawa, Kazuo Koseki, Masahiro Sato, Kayoko Tsukamoto, Kazuhisa Yamashita, Shizuya J Atheroscler Thromb Statement Japan Atherosclerosis Society 2018-08-01 /pmc/articles/PMC6099074/ /pubmed/29899173 http://dx.doi.org/10.5551/jat.45229 Text en 2018 Japan Atherosclerosis Society This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.http://creativecommons.org/licenses/by-nc-sa/3.0/ |
spellingShingle | Statement Nohara, Atsushi Ohmura, Hirotoshi Okazaki, Hiroaki Ogura, Masatsune Kitagawa, Kazuo Koseki, Masahiro Sato, Kayoko Tsukamoto, Kazuhisa Yamashita, Shizuya Statement for Appropriate Clinical Use of PCSK9 Inhibitors |
title | Statement for Appropriate Clinical Use of PCSK9 Inhibitors |
title_full | Statement for Appropriate Clinical Use of PCSK9 Inhibitors |
title_fullStr | Statement for Appropriate Clinical Use of PCSK9 Inhibitors |
title_full_unstemmed | Statement for Appropriate Clinical Use of PCSK9 Inhibitors |
title_short | Statement for Appropriate Clinical Use of PCSK9 Inhibitors |
title_sort | statement for appropriate clinical use of pcsk9 inhibitors |
topic | Statement |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099074/ https://www.ncbi.nlm.nih.gov/pubmed/29899173 http://dx.doi.org/10.5551/jat.45229 |
work_keys_str_mv | AT noharaatsushi statementforappropriateclinicaluseofpcsk9inhibitors AT ohmurahirotoshi statementforappropriateclinicaluseofpcsk9inhibitors AT okazakihiroaki statementforappropriateclinicaluseofpcsk9inhibitors AT oguramasatsune statementforappropriateclinicaluseofpcsk9inhibitors AT kitagawakazuo statementforappropriateclinicaluseofpcsk9inhibitors AT kosekimasahiro statementforappropriateclinicaluseofpcsk9inhibitors AT satokayoko statementforappropriateclinicaluseofpcsk9inhibitors AT tsukamotokazuhisa statementforappropriateclinicaluseofpcsk9inhibitors AT yamashitashizuya statementforappropriateclinicaluseofpcsk9inhibitors |